SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0000950170-24-044148
Filing Date
2024-04-12
Accepted
2024-04-12 17:23:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B4 apvo-2024-424b4_-_4.12.htm 424B4 327487
2 GRAPHIC img89397068_0.jpg GRAPHIC 6733
3 GRAPHIC img89397068_1.jpg GRAPHIC 59612
4 GRAPHIC img89397068_2.jpg GRAPHIC 528046
5 GRAPHIC img89397068_3.jpg GRAPHIC 4584
  Complete submission text file 0000950170-24-044148.txt   1153649
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-278103 | Film No.: 24842474
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)